NCT02571140View on ClinicalTrials.gov

A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

August 31, 2017

Study Completion Date

October 31, 2017

Conditions

Drug Safety and Bioavailability

Interventions

DRUG

Teriparatide

subcutaneous standard injection

DRUG

Oral PTH (1-34)

Different optimization of API

Sponsors

Lead Sponsor

Entera Bio Ltd.

All Listed Sponsors

lead

Entera Bio Ltd.

INDUSTRY